Forced Expiratory Flow Rates
"Forced Expiratory Flow Rates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The rate of airflow measured during a FORCED VITAL CAPACITY determination.
| Descriptor ID |
D005540
|
| MeSH Number(s) |
E01.370.386.700.660.225 G09.772.650.300
|
| Concept/Terms |
Forced Expiratory Flow Rates- Forced Expiratory Flow Rates
- Expiratory Forced Flow Rates
- Flow Rates, Expiratory Forced
- Flow Rates, Forced Expiratory
|
Below are MeSH descriptors whose meaning is more general than "Forced Expiratory Flow Rates".
Below are MeSH descriptors whose meaning is more specific than "Forced Expiratory Flow Rates".
This graph shows the total number of publications written about "Forced Expiratory Flow Rates" by people in this website by year, and whether "Forced Expiratory Flow Rates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Forced Expiratory Flow Rates" by people in Profiles.
-
Rabe KF, Halpin DMG, Han MK, Miravitlles M, Singh D, Gr?nke L, Vo? F, Martinez FJ. Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial. Respir Res. 2020 Jul 09; 21(1):177.
-
Vasilopoulos T, Kremen WS, Grant MD, Panizzon MS, Xian H, Toomey R, Lyons MJ, Jacobson KC, Franz CE. Individual differences in cognitive ability at age 20 predict pulmonary function 35 years later. J Epidemiol Community Health. 2015 Mar; 69(3):261-5.
-
Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010 Sep 01; 182(5):598-604.
-
Flume PA, Robinson KA, O'Sullivan BP, Finder JD, Vender RL, Willey-Courand DB, White TB, Marshall BC. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care. 2009 Apr; 54(4):522-37.
-
Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, Dockhorn RJ, Grossman J, Liddle RF, Yancey SW, et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med. 1992 Nov 12; 327(20):1420-5.